Physician profile
Sila Bal
NPI 1417451246
$22,712.73
in general payments reported to CMS, 2019-2025
12 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.82 · 2022: $1,459 · 2023: $1,541 · 2024: $2,033 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $2,463 · Travel and Lodging: $1,843 · Long Term Medical Supply Or Device Loan: $838.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,050.00 |
| Food and Beverage | $2,463.16 |
| Travel and Lodging | $1,842.81 |
| Long Term Medical Supply Or Device Loan | $838.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $16,177.19 | 2022-2025 | Epioxa, Travoprost Intraocular Implant - Idose, Idosetr |
| Johnson & Johnson Surgical Vision, INC. | $2,598.17 | 2023-2025 | Tecnis Simplicity, Tecnis Iol, Catalys System |
| Alcon Vision LLC | $1,268.77 | 2021-2025 | Unity, Clareon Panoptix Pro |
| Carl Zeiss Meditec, INC. | $1,071.19 | 2022 | |
| Biotissue Holdings INC. | $391.03 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $319.54 | 2023 | Tecnis Simplicity |
| Tarsus Pharmaceuticals, INC. | $284.79 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $179.69 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Dompe US, INC. | $127.79 | 2022 | |
| Mallinckrodt Hospital Products INC. | $114.97 | 2025 | Acthar |
| New World Medical,INC. | $95.50 | 2023 | |
| Rxsight INC | $84.10 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sila Bal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.